TS

Tim Shannon

General Partner at Canaan

Westport, Connecticut

VC
Investor

Invests in

Stages:

Series A
Seed

Sectors:

Pharmaceuticals
BioTech
Health & Hospital Services
Health IT
New York City

Locations:

Westport, Connecticut
New York, New York
  • Min Investment:

    $250,000.00
  • Max Investment:

    $20,000,000.00
  • Target Investment:

    $10,000,000.00

Education

  • AC

    BA

    Amherst College

    (1977 - 1981)

  • TU

    The University of Connecticut Health Center

Lists including Tim

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Investments

Acesion Pharma

Series B

Total Funding: $51M

Aer Therapeutics

Series A

Total Funding: $36M

Normunity

Series A

Total Funding: $65M

Rallybio

Series A

Total Funding: $180M

NextCure

Series A

Total Funding: $160M

Arvinas

Series A

Total Funding: $140M

IDEAYA Biosciences

Series A

Total Funding: $140M

Vivace Therapeutics

Series B

Total Funding: $25M

Spyryx Biosciences

Series A

Total Funding: $18M

CytomX Therapeutics

Series B

Total Funding: $61M

Work Experience

C
Canaan

2009

  • General Partner

    2009

CuraGen Corporation

2002 - 2009

  • President and CEO

    2002 - 2009

Bayer HealthCare

1992 - 2002

  • SVP Clinical Development

    1992 - 2002

All information is sourced from public domain and might be inaccurate.

|

By continuing, you're agreeing to our Terms and Privacy Policy.

|

Learn more About The Network.